Vimarsana
Biggest News Aggregation in the World

Reperfusion Damage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reperfusion Damage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reperfusion Damage Today - Breaking & Trending Today

International Stroke Conference 2024 to Present High-Profile Late-Breaking Science - Vimarsana News

International Stroke Conference 2024 to Present High-Profile Late-Breaking Science

Published: January 23, 2024

The International Stroke Conference 2024 will be held Feb. 7-9 in Phoenix, Arizona. According to program planners with the American Stroke Association, a division of the American Heart Association, findings from late-breaking science will include multiple high profile randomized clinical trials like RESILIENT-Extend, EMBOLISE, STEM, ZODIAC, among many others.

Source: dicardiology.com
Related Topics:
New YorkUnited StatesIsrael GeneralHong KongPalo AltoUxin JiangUniversity Of Hong KongHong Kong GeneralXin ChengYing MaoSoult UkpyolsiSouth KoreaComunidad Autonoma De CatalunaUrs FischerAnne AlexandrovAshkan ShamaneshMarc RiboZixiao LiGregory AlbersSteven GreenbergMadam ArthurYilong WangRadoslav RaychevSupurna GhoshLos Angeles
Investegate |GNT Pharma Co., Ltd Announcements | GNT Pharma Co., Ltd: GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN) - Vimarsana News

Investegate |GNT Pharma Co., Ltd Announcements | GNT Pharma Co., Ltd: GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN)

Published: September 19, 2022

Investegate announcements from GNT Pharma Co., Ltd, GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN)

Source: investegate.co.uk
Related Topics:
Soult UkpyolsiSouth KoreaByoung Joo GwagDennisw ChoiByung Chul KimChang Geun KimApeloa Pharmaceutical Of Hengdian GroupNational Institutes Of Health Stroke ScaleKorea Ministry Of FoodSeoul Asan Medical CenterPhd Us OfficePharma IncProvides UpdateTwo PhaseAcute Ischemic Stroke Patients TreatedEndovascular ThrombectomyIschemic StrokeReperfusion DamageCerebral InfarctionRankin ScaleStony Brook MedicineNational InstitutesHealth Stroke ScaleApeloa PharmaceuticalHengdian Group